Inhibrx Biosciences, Inc.
INBX
$12.33
$0.181.48%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 152.60M | 196.33M | 226.86M | -- | 277.92M |
| Total Receivables | 420.00K | 1.13M | 1.39M | 304.00K | 778.00K |
| Inventory | 2.00M | 3.06M | 4.93M | 8.31M | 9.89M |
| Prepaid Expenses | 4.19M | 5.09M | 6.80M | 3.99M | 5.67M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.20M | 1.84M | 2.08M | 1.58M | 1.09M |
| Total Current Assets | 160.40M | 207.45M | 242.06M | 14.18M | 295.36M |
|
|
|||||
| Total Current Assets | 160.40M | 207.45M | 242.06M | 14.18M | 295.36M |
| Net Property, Plant & Equipment | 13.54M | 8.40M | 9.62M | 9.45M | 9.37M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.83M | 6.71M | 6.75M | 4.59M | 3.16M |
| Total Assets | 180.77M | 222.56M | 258.42M | 28.22M | 307.89M |
|
|
|||||
| Total Accounts Payable | 14.89M | 13.65M | 17.56M | 17.54M | 33.76M |
| Total Accrued Expenses | 24.25M | 28.61M | 19.32M | 18.78M | 20.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.60M | 1.84M | 2.17M | 2.12M | 2.06M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 40.73M | 44.10M | 39.05M | 38.43M | 56.31M |
|
|
|||||
| Total Current Liabilities | 40.73M | 44.10M | 39.05M | 38.43M | 56.31M |
| Long-Term Debt | -- | -- | -- | -- | 206.97M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.45M | -- | -- | 561.00K | 1.11M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 47.18M | 44.10M | 39.05M | 38.99M | 264.39M |
|
|
|||||
| Common Stock & APIC | 239.72M | 236.73M | 233.77M | -10.77M | 657.24M |
| Retained Earnings | -106.13M | -58.27M | -14.40M | -- | -613.73M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 133.58M | 178.47M | 219.37M | -10.77M | 43.50M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 133.58M | 178.47M | 219.37M | -10.77M | 43.50M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 133.58M | 178.47M | 219.37M | -10.77M | 43.50M |
|
|
|||||